FDA Inspection 1039891 — Jaroslaw Trebacz
The FDA completed an inspection of Jaroslaw Trebacz on Oct 19, 2017 in Cracow. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 19, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Cracow (Poland)
Additional details
Clinical Investigator (CI)